Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma.
Saori MishimaAkihito KawazoeHiroshi MatsumotoYasutoshi KubokiHideaki BandoTakashi KojimaToshihiko DoiAtsushi OhtsuTakayuki YoshinoElizabeth M NonteSudhakar ChintharlapalliAejaz NasirTakeshi KuwataKohei ShitaraPublished in: ESMO open (2018)
RAM-CTx showed a promising activity without severe or unexpected safety profile in pts with G-NEC. This may in part be explained by higher vascular VEGFR2 expression in G-NEC tissues.